First prophylactic vaccine to demonstrate proof of concept for CMV control independent of human leukocyte antigen (HLA) status in stem cell transplant recipients DUARTE, Calif.--(BUSINESS WIRE)--City ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback